tiprankstipranks
Trending News
More News >
OncoArendi Therapeutics SA (DE:1B1)
:1B1
Germany Market
Advertisement

OncoArendi Therapeutics SA (1B1) Ratios

Compare
0 Followers

OncoArendi Therapeutics SA Ratios

DE:1B1's free cash flow for Q1 2025 was zł0.00. For the 2025 fiscal year, DE:1B1's free cash flow was decreased by zł and operating cash flow was zł0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
10.28 10.87 10.74 18.81 19.67
Quick Ratio
10.28 10.87 10.74 18.81 20.23
Cash Ratio
10.06 10.59 9.40 16.55 18.22
Solvency Ratio
-2.79 -2.25 -0.82 -1.28 6.75
Operating Cash Flow Ratio
-7.10 -3.85 -1.46 -2.19 8.69
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 5.02 0.00
Net Current Asset Value
zł 32.33Mzł 54.37Mzł 63.38Mzł 105.49Mzł 119.99M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.06 0.05 0.04 0.03
Debt-to-Equity Ratio
0.07 0.07 0.05 0.04 0.04
Debt-to-Capital Ratio
0.06 0.07 0.05 0.04 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.11 1.09 1.07 1.07
Debt Service Coverage Ratio
-236.09 -285.94 -1.84K 4.97 3.28K
Interest Coverage Ratio
-281.30 -360.18 -1.04K -2.21K 3.75K
Debt to Market Cap
0.00 0.00 0.00 >-0.01 0.00
Interest Debt Per Share
0.34 0.43 0.46 0.43 0.39
Net Debt to EBITDA
1.32 2.23 1.86 7.20 -1.56
Profitability Margins
Gross Profit Margin
-23697.55%-4101610.00%-1.32%-693272.50%68.76%
EBIT Margin
-212128.16%-28373116.00%-2221.17%-3407520.50%59.95%
EBITDA Margin
-184178.44%-25505806.00%-1974.24%-3332504.75%60.10%
Operating Profit Margin
-219447.53%-32128045.00%-1053.00%-3441074.75%59.95%
Pretax Profit Margin
-212578.25%-28373117.00%-946.15%-3409079.75%59.91%
Net Profit Margin
-212578.25%-28373117.00%-839.31%-3410639.00%55.28%
Continuous Operations Profit Margin
-212578.25%-28373117.00%-2228.51%-3409079.75%55.28%
Net Income Per EBT
100.00%100.00%88.71%100.05%92.27%
EBT Per EBIT
96.87%88.31%89.85%99.07%99.93%
Return on Assets (ROA)
-27.58%-25.27%-9.81%-9.00%44.28%
Return on Equity (ROE)
-32.20%-28.11%-10.71%-9.67%47.39%
Return on Capital Employed (ROCE)
-29.58%-30.24%-12.96%-9.46%50.18%
Return on Invested Capital (ROIC)
-29.12%-29.64%-11.31%-9.53%43.25%
Return on Tangible Assets
-58.94%-37.18%-15.63%-10.83%49.26%
Earnings Yield
-19.35%-8.64%-6.77%-2.61%9.88%
Efficiency Ratios
Receivables Turnover
0.04 0.01 0.00 0.00 0.00
Payables Turnover
2.06 9.11 0.58 1.40 47.01
Inventory Turnover
0.00 0.00 0.00 0.00 -10.41
Fixed Asset Turnover
<0.01 <0.01 0.14 <0.01 15.58
Asset Turnover
<0.01 <0.01 0.01 <0.01 0.80
Working Capital Turnover Ratio
<0.01 <0.01 0.02 <0.01 1.59
Cash Conversion Cycle
8.32K 35.13K -630.34 -261.30 -42.81
Days of Sales Outstanding
8.49K 35.18K 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 -35.05
Days of Payables Outstanding
176.77 40.07 630.34 261.30 7.76
Operating Cycle
8.49K 35.18K 0.00 0.00 -35.05
Cash Flow Ratios
Operating Cash Flow Per Share
-1.42 -1.38 -0.73 -0.97 4.22
Free Cash Flow Per Share
-2.30 -3.35 -3.13 -2.32 4.07
CapEx Per Share
0.88 2.01 2.40 1.35 0.15
Free Cash Flow to Operating Cash Flow
1.62 2.42 4.29 2.40 0.96
Dividend Paid and CapEx Coverage Ratio
-1.61 -0.69 -0.30 -0.72 27.53
Capital Expenditure Coverage Ratio
-1.61 -0.69 -0.30 -0.72 27.53
Operating Cash Flow Coverage Ratio
-4.29 -3.26 -1.59 -2.25 10.98
Operating Cash Flow to Sales Ratio
-2.06K -232.90K -6.33 -33.74K 0.47
Free Cash Flow Yield
-29.81%-17.17%-21.91%-6.20%8.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-5.17 -11.57 -14.78 -38.25 10.13
Price-to-Sales (P/S) Ratio
11.20K 3.28M 124.02 1.30M 5.60
Price-to-Book (P/B) Ratio
1.56 3.25 1.58 3.70 4.80
Price-to-Free Cash Flow (P/FCF) Ratio
-3.36 -5.82 -4.56 -16.14 12.43
Price-to-Operating Cash Flow Ratio
-5.34 -14.10 -19.59 -38.66 11.98
Price-to-Earnings Growth (PEG) Ratio
-0.64 -0.16 14.48 0.32 >-0.01
Price-to-Fair Value
1.56 3.25 1.58 3.70 4.80
Enterprise Value Multiple
-4.76 -10.64 -4.42 -31.94 7.75
Enterprise Value
122.21M 271.45M 140.86M 425.76M 572.89M
EV to EBITDA
-4.76 -10.64 -4.42 -31.94 7.75
EV to Sales
8.77K 2.71M 87.31 1.06M 4.66
EV to Free Cash Flow
-2.63 -4.81 -3.21 -13.17 10.35
EV to Operating Cash Flow
-4.26 -11.66 -13.79 -31.55 9.97
Tangible Book Value Per Share
2.03 3.86 5.35 8.28 9.40
Shareholders’ Equity Per Share
4.86 5.99 9.01 10.12 10.54
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.11 >-0.01 0.13
Revenue Per Share
<0.01 <0.01 0.11 <0.01 9.04
Net Income Per Share
-1.47 -1.69 -0.97 -0.98 5.00
Tax Burden
1.00 1.00 0.89 1.00 0.92
Interest Burden
1.00 1.00 0.43 1.00 1.00
Research & Development to Revenue
123.91 27.19K 1.06 6.47K 0.31
SG&A to Revenue
0.00 0.00 3.74 10.07K 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.27 7.09K 0.00
Income Quality
0.97 0.82 0.67 0.99 0.89
Currency in PLN
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis